| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
COLORECTAL CANCER |
1 Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
2 Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden
3 Department of Odontology, Cardiology, Umeå University, Umeå, Sweden
4 Department of Public Health and Clinical Medicine, Nutrition Research, Umeå University, Umeå, Sweden
5 Department of Epidemiology, Imperial College London, London, UK
6 Department of Clinical Nutrition, The Sahlgrenska Academy, Göteborg University, Gothenburg, Sweden
Correspondence to:
Correspondence to:
MsB Van Guelpen
Department of Medical Biosciences, Pathology, Building 6M, 2nd Floor, Umeå University, SE-901 85 Umeå, Sweden; bethany.van.guelpen{at}medbio.umu.se
ABSTRACT
Background and aims: Dietary folate is believed to protect against colorectal cancer (CRC). However, few studies have addressed the role of circulating levels of folate. The aim of this study was to relate prediagnostic plasma folate and homocysteine concentrations and the methylenetetrahydrofolate reductase (MTHFR) 677C>T and 1298A>C polymorphisms to the risk of developing CRC.
Subjects: Subjects were 226 cases and 437 matched referents from the population based Northern Sweden Health and Disease Cohort.
Results: We observed a bell-shaped association between plasma folate concentrations and CRC risk; multivariate odds ratio for middle versus lowest quintile 2.00 (95% confidence interval (CI) 1.13–3.56). In subjects with follow up times greater than the median of 4.2 years however, plasma folate concentrations were strongly positively related to CRC risk; multivariate odds ratio for highest versus lowest quintile 3.87 (95% CI 1.52–9.87; p trend = 0.007). Homocysteine was not associated with CRC risk. Multivariate odds ratios for the MTHFR polymorphisms were, for 677 TT versus CC, 0.41 (95% CI 0.19–0.85; p trend = 0.062), and for 1298 CC versus AA, 1.62 (95% CI 0.94–2.81; p trend = 0.028). Interaction analysis suggested that the result for 1298A>C may have been largely due to linkage disequilibrium with 677C>T. The reduced CRC risk in 677 TT homozygotes was independent of plasma folate status.
Conclusions: Our findings suggest a decreased CRC risk in subjects with low folate status. This possibility of a detrimental component to the role of folate in carcinogenesis could have implications in the ongoing debate in Europe concerning mandatory folate fortification of foods.
Abbreviations: CRC, colorectal cancer; MTHFR, methylenetetrahydrofolate reductase; MONICA, Northern Sweden WHO Monitoring of Trends and Cardiovascular Disease Study; VIP, Västerbotten Intervention Project; MSP, Mammography Screening Project; OR, odds ratio; BMI, body mass index
Keywords: colorectal neoplasm; folate; homocysteine; methylenetetrahydrofolate reductase; risk factors
Relevant Article
Gut 2006 55: 1387-1389.
This article has been cited by other articles:
|
|
 |
|
  S. de Vogel, V. Dindore, M. van Engeland, R. A. Goldbohm, P. A. van den Brandt, and M. P. Weijenberg Dietary Folate, Methionine, Riboflavin, and Vitamin B-6 and Risk of Sporadic Colorectal Cancer J. Nutr., December 1, 2008; 138(12): 2372 - 2378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Weinstein, D. Albanes, J. Selhub, B. Graubard, U. Lim, P. R. Taylor, J. Virtamo, and R. Stolzenberg-Solomon One-Carbon Metabolism Biomarkers and Risk of Colon and Rectal Cancers Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3233 - 3240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B Michels The promise and challenges of population strategies of prevention Int. J. Epidemiol., October 1, 2008; 37(5): 914 - 916. [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Wali, D. P. Kunte, J. L. Koetsier, M. Bissonnette, and H. K. Roy Polyethylene glycol-mediated colorectal cancer chemoprevention: roles of epidermal growth factor receptor and Snail Mol. Cancer Ther., September 1, 2008; 7(9): 3103 - 3111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Wolpin, E. K. Wei, K. Ng, J. A. Meyerhardt, J. A. Chan, J. Selhub, E. L. Giovannucci, and C. S. Fuchs Prediagnostic Plasma Folate and the Risk of Death in Patients With Colorectal Cancer J. Clin. Oncol., July 1, 2008; 26(19): 3222 - 3228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A D. Smith, Y.-I. Kim, and H. Refsum Is folic acid good for everyone? Am. J. Clinical Nutrition, March 1, 2008; 87(3): 517 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Marsillach, N. Ferre, J. Camps, F. Riu, A. Rull, and J. Joven Moderately High Folic Acid Supplementation Exacerbates Experimentally Induced Liver Fibrosis in Rats Experimental Biology and Medicine, January 1, 2008; 233(1): 38 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M Pfeiffer, C. L Johnson, R. B Jain, E. A Yetley, M. F. Picciano, J. I Rader, K. D Fisher, J. Mulinare, and J. D Osterloh Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004 Am. J. Clinical Nutrition, September 1, 2007; 86(3): 718 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J Wald and G. P Oakley Should folic acid fortification be mandatory? Yes BMJ, June 16, 2007; 334(7606): 1252 - 1252. [Full Text] [PDF]
|
|
|
|
|
|
R. A Hubner, R. D Houlston, and K. R Muir Should folic acid fortification be mandatory? No BMJ, June 16, 2007; 334(7606): 1253 - 1253. [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Cole, J. A. Baron, R. S. Sandler, R. W. Haile, D. J. Ahnen, R. S. Bresalier, G. McKeown-Eyssen, R. W. Summers, R. I. Rothstein, C. A. Burke, et al. Folic Acid for the Prevention of Colorectal Adenomas: A Randomized Clinical Trial JAMA, June 6, 2007; 297(21): 2351 - 2359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Hubner, S. Lubbe, I. Chandler, and R. S. Houlston MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer Hum. Mol. Genet., May 1, 2007; 16(9): 1072 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, Q. Ke, W. Chen, J. Wang, Y. Tan, Y. Zhou, Z. Hua, W. Ding, J. Niu, J. Shen, et al. Polymorphisms of MTHFD, Plasma Homocysteine Levels, and Risk of Gastric Cancer in a High-Risk Chinese Population Clin. Cancer Res., April 15, 2007; 13(8): 2526 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Abstracts Gut, April 1, 2007; 56(suppl_2): a1 - a145. [Full Text] [PDF]
|
|
|
|
|
|
Poster Abstracts J. Nutr., January 1, 2007; 137(1): 278S - 295S. [Full Text] [PDF]
|
|
|
|
|
|
Y-I Kim Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut, October 1, 2006; 55(10): 1387 - 1389. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
